Effect of Corticosteroid Therapy on Ventricular Arrhythmias in Patients with Cardiac Sarcoidosis
Authors:
- 18 April 2011
- journal article
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 16 (2) , 140-147
Abstract
Background: Ventricular arrhythmias are one of the main causes of sudden death in cardiac sarcoidosis (CS). Little is known about the efficacy of corticosteroid therapy for ventricular arrhythmias in CS. Methods: Thirty‐one CS patients presenting premature ventricular contractions (PVCs, ≥300/day) were investigated. Fourteen patients had nonsustained ventricular tachycardia (NSVT). All of patients were treated with corticosteroid, and the initial dosage is 30 mg/day of prednisone, which was tapered over a period of 6 months to a maintenance dosage of 10 mg/day. Twenty‐four hour Holter monitoring, signal averaged electrocardiography (SAECG), echocardiography, gallium‐67 scintigraphy, serum angiotensin converting enzyme (ACE) and plasma B‐type natriuretic peptide (BNP) concentrations were assessed before and after corticosteroid therapy. Results: As a whole, there were no significant differences in the number of PVCs and in the prevalence of NSVT before and after steroid therapy. However, the less advanced LV dysfunction patients (EF ≥ 35%, n = 17) showed significant reduction in the number of PVCs (from 1820 ± 2969 to 742 ± 1425, P = 0.048) and in the prevalence of NSVT (from 41 to 6%, p = 0.039). Late potentials on SAECG were abolished in 3 patients. The less advanced LV dysfunction group showed a significantly higher prevalence of gallium‐67 uptake compared with the advanced LV dysfunction group (EF < 35 %, n = 14). In the advanced LV dysfunction patients, there were no significant differences in these parameters. Conclusions: Corticosteroid therapy may be effective for ventricular arrhythmias in the early stage, but less effective in the late stage. Ann Noninvasive Electrocardiol 2011;16(2):140–147Keywords
This publication has 27 references indexed in Scilit:
- Detection of Myocardial Damage in Patients With SarcoidosisCirculation, 2009
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesCirculation, 2008
- Ventricular tachyarrhythmia as a primary presentation of sarcoidosisEP Europace, 2008
- Postpartum Complete Atrioventricular Block Due to Cardiac Sarcoidosis Steroid Therapy Without Permanent PacemakerInternational Heart Journal, 2008
- Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardiaThe International Journal of Cardiovascular Imaging, 2006
- Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatterInternational Journal of Cardiology, 2005
- Evaluation of the Accuracy of Gadolinium-Enhanced Cardiovascular Magnetic Resonance in the Diagnosis of Cardiac SarcoidosisJACC, 2005
- Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosisThe American Journal of Cardiology, 2005
- Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia deviceJACC, 1991
- The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: A prospective studyJACC, 1989